o2h ChaiTime on Virtual, SemiVirtual and Open Innovation operational models to deliver Faster and Cheaper drugs to patients with superior returns for investors.
CEO and Co-Founder of Inflazome, he started the virtual company in 2016 and in super-fast time this month sold the business to Roche for $450m upfront with further milestone payments.
President and Co-Founder of Astex Pharmaceuticals, a therapeutics business that he later sold to Otsuka for $886m.
Professor Chas Bountra is Pro Vice-Chancellor for Innovation at the University of Oxford. he is Associate Member of the Department of Pharmacology at the University of Oxford.